SR
MET icon

Swiss Re’s MetLife MET Stock Holding History

Swiss Re’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-254
Closed -$18K – 262
2026
Q1 		$18K Hold
254
– – 0.11% 141
2025
Q4 		$20.1K Buy
+254
New +$20.1K ﹤0.01% 126

Other funds holding MET

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Swiss Re's MET Position: Q2 2026 in Review

Swiss Re sold out of MetLife (MET) in Q2 2026, closing a stake of 254 shares — an estimated $18K sold.

Swiss Re first reported a position in MET in Q4 2025 and held it in 2 quarters. The position peaked at $20.1K in Q4 2025. 1,442 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Swiss Re reported no remaining MetLife position as of Q2 2026 after selling out during the quarter.
  • Swiss Re sold 254 MetLife shares in Q2 2026, an estimated $18K.
  • Swiss Re first reported a position in MetLife in Q4 2025 and held it in 2 quarters.
  • Swiss Re's MetLife position peaked at $20.1K in Q4 2025.
  • 1,442 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Swiss Re's 13F filing for Q2 2026, filed 11 Aug 2026.